IBEX (NASDAQ:IBEX – Get Free Report) released its earnings results on Thursday. The company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.20, FiscalAI reports. IBEX had a return on equity of 29.98% and a net margin of 7.34%. The firm had revenue of $175.23 million for the quarter, compared to analysts’ expectations of $169.31 million.
Here are the key takeaways from IBEX’s conference call:
- IBEX reported 16% revenue growth to a record $175.2 million in Q1, its seventh consecutive quarter of double-digit growth. Adjusted EBITDA rose 29% to a record $25.2 million, and adjusted EBITDA margin expanded 150 basis points to 14.4%.
- The company raised FY2027 guidance: revenue is now expected to be $720 million–$735 million, up from $700 million–$715 million, while adjusted EBITDA guidance increased to $96 million–$99 million from $90 million–$94 million. Management expects 50–70 basis points of full-year margin improvement and year-over-year EBITDA improvement in each remaining quarter, though not at Q1’s pace.
- New client wins and expansion with existing customers both supported growth: recent new-logo cohorts accounted for about 50% of Q1 revenue growth, while revenue from the top five, top 10, and top 25 clients grew 14%, 13%, and 18%, respectively. Management said client retention remains above 99%.
- IBEX said its Sierra partnership is generating demand for combined AI-agent and human-support offerings, including four AI-agent deals since the quarter and three additional verbal traditional BPO wins. In one example, an AI deployment reduced abandoned calls by more than 60% and helped IBEX win the client’s traditional call-center work.
IBEX Trading Up 15.2%
Shares of IBEX traded up $6.52 during trading hours on Friday, hitting $49.52. The company had a trading volume of 414,464 shares, compared to its average volume of 90,691. The company has a market capitalization of $660.60 million, a PE ratio of 15.01 and a beta of 0.74. IBEX has a one year low of $25.94 and a one year high of $49.89. The company’s fifty day moving average price is $43.00 and its two-hundred day moving average price is $34.50.
Insider Buying and Selling at IBEX
In other news, insider Julie K. Casteel sold 17,474 shares of the firm’s stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $40.41, for a total value of $706,124.34. Following the completion of the sale, the insider owned 100,814 shares of the company’s stock, valued at $4,073,893.74. This trade represents a 14.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Paul Inson sold 2,500 shares of the business’s stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $40.07, for a total value of $100,175.00. Following the transaction, the insider owned 27,224 shares in the company, valued at approximately $1,090,865.68. This trade represents a 8.41% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 97,465 shares of company stock valued at $3,882,291. 3.40% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on the company. Robert W. Baird lifted their target price on IBEX from $40.00 to $44.00 and gave the stock a “neutral” rating in a research report on Monday, September 28th. Wall Street Zen upgraded shares of IBEX from a “buy” rating to a “strong-buy” rating in a report on Saturday. Finally, Weiss Ratings raised shares of IBEX from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, October 12th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, IBEX currently has a consensus rating of “Hold” and an average target price of $42.00.
View Our Latest Stock Analysis on IBEX
IBEX Company Profile
IBEX Limited (NASDAQ: IBEX) is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services.
The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.
Featured Stories
- Five stocks we like better than IBEX
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for IBEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBEX and related companies with MarketBeat.com's FREE daily email newsletter.
